Étude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501)-Reference-Cited by-同舟云学术

Étude de phase 2, randomisée, évaluant une polychimiothérapie orale (CCNU, Cyclophosphamide, étoposide) et une polychimiothérapie intraveineuse dans les cancers bronchiques à petites cellules en seconde ligne en rechute (essai GFPC0501)

Published:2007-05 Issue:5 Volume:24 Page:653-658
ISSN:0761-8425
Container-title:Revue des Maladies Respiratoires
language:fr
Short-container-title:Revue des Maladies Respiratoires

Author:

Gervais R.,Le Guen Y.,Le Caer H.,Paillotin D.,Chouaid C.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. Treatment options for patients with relapsed small cell lung cancer;Greco;Lung Cancer,1993

2. Pretreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy;Postmus;Eur J Cancer Clin Oncol,1987

3. Treatment of relapsed small cell lung cancer;Postmus;Semin Oncol,2001

4. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial;Faylona;J Clin Oncol,1995

5. Second-line chemotherapy and its evaluation in small cell lung cancer;Huisman;Cancer Treat Rev,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimiothérapie métronomique en 2011 : actualités et perspectives;Bulletin du Cancer;2011-12

2. Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer;BMC Cancer;2010-08-17

3. Oral second- and third-line lomustine–etoposide–cyclophosphamide chemotherapy for small cell lung cancer;Lung Cancer;2010-02